Antidepressant efficacy and safety of scopolamine in individuals with bipolar disorder (SCOPE-BD): A randomized double-blind placebo-controlled trial.
- DOI
- 10.1016/j.jad.2025.120888
- Published
- 2026 Mar 15
- Container
- Journal of affective disorders
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jad.2025.120888,
title = {Antidepressant efficacy and safety of scopolamine in individuals with bipolar disorder (SCOPE-BD): A randomized double-blind placebo-controlled trial.},
author = {Miravalles C and Kane R and Rossier AT and Quirke J and Aguilar Macías DA and Alvarez-Iglesias A and Chukwudi K and McDonald C and Cannon DM and Hallahan B},
year = {2026},
journal = {Journal of affective disorders},
doi = {10.1016/j.jad.2025.120888},
url = {https://doi.org/10.1016/j.jad.2025.120888}
}RIS
TY - JOUR TI - Antidepressant efficacy and safety of scopolamine in individuals with bipolar disorder (SCOPE-BD): A randomized double-blind placebo-controlled trial. AU - Miravalles C AU - Kane R AU - Rossier AT AU - Quirke J AU - Aguilar Macías DA AU - Alvarez-Iglesias A AU - Chukwudi K AU - McDonald C AU - Cannon DM AU - Hallahan B PY - 2026 JO - Journal of affective disorders DO - 10.1016/j.jad.2025.120888 UR - https://doi.org/10.1016/j.jad.2025.120888 ER -
APA
C, M., R, K., AT, R., J, Q., DA, A. M., A, A., K, C., C, M., DM, C., & B, H. (2026). Antidepressant efficacy and safety of scopolamine in individuals with bipolar disorder (SCOPE-BD): A randomized double-blind placebo-controlled trial.. Journal of affective disorders. https://doi.org/10.1016/j.jad.2025.120888
Source records
- pubmed · retrieved 2026-09-26T12:26:49.038Z
- europe-pmc · retrieved 2026-09-26T12:26:49.032Z